Seto T - Search Results

1

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours.

Paz-Ares L, Barlesi F, Siena S, Ahn MJ, Drilon A, Conley A, Rolfo C, Wolf J, Seto T, Doebele R, Kapre A, Chen D, McCallum S, Osborne S, Demetri G. Paz-Ares L, et al. Among authors: seto t. ESMO Open. 2021 Jun;6(3):100113. doi: 10.1016/j.esmoop.2021.100113. Epub 2021 Apr 27. ESMO Open. 2021. PMID: 33930659 Free PMC article. Clinical Trial.

2

Prognostic factors in previously treated non-small cell lung cancer patients with and without a positive response to the subsequent treatment with gefitinib.

Wataya H, Okamoto T, Maruyama R, Seto T, Yamazaki K, Tagawa T, Fukuyama S, Osoegawa A, Ikeda J, Nishimura M, Yamanaka T, Ichinose Y. Wataya H, et al. Among authors: seto t. Lung Cancer. 2009 Jun;64(3):341-5. doi: 10.1016/j.lungcan.2008.09.005. Epub 2008 Nov 7. Lung Cancer. 2009. PMID: 18995926

3

Treatment after the failure of gefitinib in patients with advanced or recurrent non-small cell lung cancer.

Maruyama R, Wataya H, Seto T, Ichinose Y. Maruyama R, et al. Among authors: seto t. Anticancer Res. 2009 Oct;29(10):4217-21. Anticancer Res. 2009. PMID: 19846976 Free article.

4

Non-small cell lung carcinoma of the superior sulcus: The evolution of treatment outcomes with multimodality treatment at a single institution.

Tagawa T, Osoegawa A, Yamazaki K, Okamoto T, Kometani T, Wataya H, Seto T, Fukuyama S, Hirai F, Sugio K, Ichinose Y. Tagawa T, et al. Among authors: seto t. J Surg Oncol. 2010 May 1;101(6):495-9. doi: 10.1002/jso.21507. J Surg Oncol. 2010. PMID: 20191604

5

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.

Seto T, Kiura K, Nishio M, Nakagawa K, Maemondo M, Inoue A, Hida T, Yamamoto N, Yoshioka H, Harada M, Ohe Y, Nogami N, Takeuchi K, Shimada T, Tanaka T, Tamura T. Seto T, et al. Lancet Oncol. 2013 Jun;14(7):590-8. doi: 10.1016/S1470-2045(13)70142-6. Epub 2013 Apr 30. Lancet Oncol. 2013. PMID: 23639470 Clinical Trial.

6

Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.

Yamaguchi M, Toyokawa G, Ohba T, Sasaki T, Kometani T, Hamatake M, Hirai F, Taguchi K, Yamanaka T, Seto T, Takenoyama M, Sugio K, Ichinose Y. Yamaguchi M, et al. Among authors: seto t. Ann Thorac Surg. 2013 Nov;96(5):1783-9. doi: 10.1016/j.athoracsur.2013.06.036. Epub 2013 Aug 30. Ann Thorac Surg. 2013. PMID: 23998404

7

Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group.

Murakami H, Yamanaka T, Seto T, Sugio K, Okamoto I, Sawa T, Hirashima T, Takeda K, Atagi S, Fukuoka M, Nakanishi Y, Nakagawa K, Yamamoto N. Murakami H, et al. Among authors: seto t. Cancer Sci. 2014 Aug;105(8):989-95. doi: 10.1111/cas.12448. Epub 2014 Jul 12. Cancer Sci. 2014. PMID: 24837137 Free PMC article. Clinical Trial.

8

Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.

Takenaka T, Takenoyama M, Yamaguchi M, Toyozawa R, Inamasu E, Kojo M, Toyokawa G, Yoshida T, Shiraishi Y, Morodomi Y, Hirai F, Taguchi K, Shimokawa M, Seto T, Ichinose Y. Takenaka T, et al. Among authors: seto t. Eur J Cardiothorac Surg. 2015 Mar;47(3):550-5. doi: 10.1093/ejcts/ezu227. Epub 2014 Jun 3. Eur J Cardiothorac Surg. 2015. PMID: 24894095

9

Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy.

Morodomi Y, Takenoyama M, Inamasu E, Toyozawa R, Kojo M, Toyokawa G, Shiraishi Y, Takenaka T, Hirai F, Yamaguchi M, Taguchi K, Seto T, Sugio K, Ichinose Y. Morodomi Y, et al. Among authors: seto t. Anticancer Res. 2014 Jul;34(7):3825-30. Anticancer Res. 2014. PMID: 24982409

10

ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?

Toyokawa G, Seto T. Toyokawa G, et al. Among authors: seto t. Clin Lung Cancer. 2014 Sep;15(5):313-9. doi: 10.1016/j.cllc.2014.05.001. Epub 2014 Jun 2. Clin Lung Cancer. 2014. PMID: 24984564 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

819 results

Search Page